Literature DB >> 12490197

PAR-1 is required for morphogenesis of the Caenorhabditis elegans vulva.

Daryl D Hurd1, Kenneth J Kemphues.   

Abstract

The Caenorhabditis elegans vulva provides a simple model for the genetic analysis of pattern formation and organ morphogenesis during metazoan development. We have discovered an essential role for the polarity protein PAR-1 in the development of the vulva. Postembryonic RNA interference of PAR-1 causes a protruding vulva phenotype. We found that depleting PAR-1 during the development of the vulva has no detectable effect on fate specification or precursor proliferation, but instead seems to specifically alter morphogenesis. Using an apical junction-associated GFP marker, we discovered that PAR-1 depletion causes a failure of the two mirror-symmetric halves of the vulva to join into a single, coherent organ. The cells that normally form the ventral vulval rings fail to make contact or adhere and consequently form incomplete toroids, and dorsal rings adopt variably abnormal morphologies. We also found that PAR-1 undergoes a redistribution from apical junctions to basolateral domains during morphogenesis. Despite a known role for PAR-1 in cell polarity, we have observed no detectable differences in the distribution of various markers of epithelial cell polarity. We propose that PAR-1 activity at the cell cortex is critical for mediating cell shape changes, cell surface composition, or cell signaling during vulval morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490197     DOI: 10.1006/dbio.2002.0866

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  29 in total

1.  Reduction in ovulation or male sex phenotype increases long-term anoxia survival in a daf-16-independent manner in Caenorhabditis elegans.

Authors:  Alexander R Mendenhall; Michelle G LeBlanc; Desh P Mohan; Pamela A Padilla
Journal:  Physiol Genomics       Date:  2008-12-02       Impact factor: 3.107

Review 2.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  The kinases PIG-1 and PAR-1 act in redundant pathways to regulate asymmetric division in the EMS blastomere of C. elegans.

Authors:  Małgorzata J Liro; Diane G Morton; Lesilee S Rose
Journal:  Dev Biol       Date:  2018-09-10       Impact factor: 3.582

4.  A microcosm of the biomedical research experience for upper-level undergraduates.

Authors:  Daryl D Hurd
Journal:  CBE Life Sci Educ       Date:  2008       Impact factor: 3.325

5.  Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis.

Authors:  M Jansen; W W J de Leng; A F Baas; H Myoshi; L Mathus-Vliegen; M M Taketo; H Clevers; F M Giardiello; G J A Offerhaus
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

6.  Regulation of the MEX-5 gradient by a spatially segregated kinase/phosphatase cycle.

Authors:  Erik E Griffin; David J Odde; Geraldine Seydoux
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

7.  Modulation of KSR activity in Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase.

Authors:  John H Yoder; Huira Chong; Kun-Liang Guan; Min Han
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

8.  A genome-wide RNAi screen for enhancers of par mutants reveals new contributors to early embryonic polarity in Caenorhabditis elegans.

Authors:  Diane G Morton; Wendy A Hoose; Kenneth J Kemphues
Journal:  Genetics       Date:  2012-08-10       Impact factor: 4.562

9.  Dorsoventral patterning of the C. elegans postembryonic mesoderm requires both LIN-12/Notch and TGFbeta signaling.

Authors:  Marisa L Foehr; Jun Liu
Journal:  Dev Biol       Date:  2007-10-25       Impact factor: 3.582

10.  Using Caenorhabditis elegans as a model organism for evaluating extracellular signal-regulated kinase docking domain inhibitors.

Authors:  Fengming Chen; Alexander D Mackerell; Yuan Luo; Paul Shapiro
Journal:  J Cell Commun Signal       Date:  2008-12-23       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.